ANO1 and cystic fibrosis: Enhancing TMEM16A‐mediated chloride secretion thereby represents a therapeutic approach to hydrating the hyperconcentrated mucus in the airways of patients with a variety of diseases associated with mucus obstruction including cystic fibrosis (CF).5, 6, 7